Avacta Share Discussion Threads

[beatme1] 07/3/2024 15:39

I've got short open since 95pLooking to close at 30/35p Avct rampers or many of them have all goneNext news wnt be for a few months yet

[tomavery19] 07/3/2024 15:36

When should we buy

[beatme1] 07/3/2024 14:29

No buy signals yet wait

[stockhunters] 07/3/2024 14:04

massive gap fill after 55p

[dalep716] 07/3/2024 13:03

Bloody phone knackered again, showing Avacta blue.

[fieldhouse] 07/3/2024 12:41

Oh josh !!
SP going up--well i never

[fieldhouse] 07/3/2024 09:39

Electric cars were going to be the future in 1900 ! Lead acid batteries were the energy source. Along came the internal combustion engine and electric cars were left standing .
Roll on a century and along comes lithium ! Electric cars are go !
Same principle --different source .

[fieldhouse] 07/3/2024 09:29

So the trials to date are a complete waste of time and the oncologist running the program is stupid !!!

As i said before Arisaph were using a different drug from Dox. A new strategy.

[ohwhatfun] 07/3/2024 08:14

Field

Everyone wishes for better cancer treatments, which makes spinning yarn (if that happens) for personal gain, all the more abhorrent.

This is a direct rehash of an abandoned plan in the US with Tufts.

Relevant staff from the collaboration ended up at Avacta (now left). It was simply taken from the defunct Arisaph to the AIM to gloss up and resell to the market.

If people have the kitchen sink in it, then it would be very wise to know what ended the progress in the US.

After all it’s now facing US permissions with no guarantee.

So what caused it to be abandoned before where at least one founder was a billionaire.

No note I have seen, mentions previous failure to progress, which makes such notes with wild claims, flawed (intentionally or by incompetence). The FDA will have records of the previous paths.

This isn’t new, Arisaph were progressing things 10-12 years ago, but the company wound up in about 2017.

Not long after Arisaph staff appear at Avacta along with the abandoned therapies.

So Avacta are now pushing for US approval, where for unknown reasons it was abandoned.

Was it regulatory failure, safety, lack of efficacy, cash/backers certainly wasn’t a problem.


In the case of pump and dump, the above is irrelevant.
In the case of a long term hold for the future of a family, it’s crazy not to seek out the truth.

If anyone trusts AIM company CEOs, then 90% of the time it’s misplaced trust in a con artist. The riches spin is the most common and easiest trick in the book.

Retail fall for it, funds, traders and shorters, rely on retail falling for it. Without large numbers of retail investors it doesn’t work.

Companies can get it working with news after news containing riches type blurb.

[amanitaangelicus] 07/3/2024 06:27

Blackvulture - the most obvious trader here. Disappears for day at a time. share price fall, up he pops. Mr Shallows way to go.

[blackvulture] 06/3/2024 20:34

I see that this bulletin board is still infested with with little children no sorry grownups which are not invested and haven't got a clue what Avacta is all about. Sad really.

[1347] 06/3/2024 18:51

Hopefully....another 20 years in you yet fieldhouse.

Avacta will probably be doing cohort 21 of Phase 2a by then.

[amanitaangelicus] 06/3/2024 16:30

You.ve been trapped Fieldhouse. Darn.

[filthypoor] 06/3/2024 13:40

Hopefully....another 20 years in you yet fieldhouse.

[countbasie1] 06/3/2024 10:14

PWYou are right. My mistake.

[ohwhatfun] 06/3/2024 08:45

The RTO minerals company chasing cancer therapeutics.

A great example of the AIM, spin and huge salaries end on one idea, so the existing AIM entity via another route fleeces the market again.

No doubt those behind it have seen how retail how reacted to one, so chase the same idea to attract hoping for the same result, buying something for peanuts then turn it into a £50m-£100m company, where nothing has actually changed.

It can be tough entering the AIM, far easier to RTO

EG some spin their world leading LFTs as worth billions, then buy into diagnostics as a big future, BUT, forget that, the new spin is keeping ‘em interested. 100’s of 1000’s bagged for a good free more years, job done boys forget all that junk we hyped up before.

And then one day in the future, reality kicks in, and the team management live happily ever after, having banked millions.

40’s next, the bounce hasn’t happened so 10’s of millions of shares bought low 50’s, in retail hands no one sell to.

[pwhite73] 06/3/2024 08:28

countbasie1 - The news may have been released last night but it certainly was not an RNS.

[countbasie1] 06/3/2024 08:15

PWThat RNS was released last night 3/5 UK time.Then it reappeared today.

[pwhite73] 06/3/2024 07:46

Note the date of 05/03/24 on both the globenewswire (above) and yahoo weblink (below). AVCT are passing it off as an RNS as of today 06/03/24.



How many presentations at the AACR have they made of this worthless witches potion.

[amanitaangelicus] 06/3/2024 07:37

'With a balanced business and capital allocation model: a high-value oncology pipeline supported by a revenue generating, fast-growing diagnostics business, Avacta seeks to create long-term shareholder value alongside patient benefit' ...from the rns.Keep pumping Time Lord Smith. The gall on him.

[melody9999] 05/3/2024 23:04

As a non-shareholder, glad I did not waste my time, and the time of my broker, on 'taking up' the REX offer.